Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nefiracetam Therapy of Alzheimer's Type Dementia
NCT00001933Phase 2
Key facts
- Status
- Completed
- Start
- Jul 1999
- Countries
- 1
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Modality
- Small Molecules
- Drugs
- nefiracetam
- Conditions
- Alzheimer's disease (AD)
01
Overview
Phase 2, randomised, double-blind trial in Alzheimer's disease (AD) comparing Nefiracetam with Placebo (2 arms). Started Jul 1999; status: completed.
02
Design
2 arms- Study design
- RandomizedDouble-blind
Nefiracetam
Nefiracetam 3 pills twice daily
Placebo
Placebo 3 pills twice daily
Beyond the preview
Go deeper on NCT00001933.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001933.